Interação medicamentosa e incompatibilidade entre Meropenem e Dobutamina utilizados em UTI neonatal: uma revisão bibliográfica
The drug interaction and incompatibility between meropenem and dobutamine used in neonatal ICU is a bibliographic review based on data collection. Research is very important for the health area, especially for newborn patients who have such a significant fragility. In this context, concepts ab...
Na minha lista:
Autor principal: | |
---|---|
Outros Autores: | |
Formato: | bachelorThesis |
Idioma: | pt_BR |
Publicado em: |
Universidade Federal do Rio Grande do Norte
|
Assuntos: | |
Endereço do item: | https://repositorio.ufrn.br/handle/123456789/53429 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Resumo: | The drug interaction and incompatibility between meropenem and dobutamine used in neonatal
ICU is a bibliographic review based on data collection. Research is very important for the health
area, especially for newborn patients who have such a significant fragility. In this context,
concepts about drug interaction, meropenem and dobutamine will be discussed, exposing works
aimed at studying such concepts and applications. It is evident that the main problem is the
scarcity of works that revolve around studying and identifying possible interactions between
meropenem and dobutamine, and thus guaranteeing the safety and efficacy of drug treatment.
Among the difficulties encountered, the objective is to understand the possible benefits, risks
and relevant clinical considerations when administering these drugs together in newborns in the
NICU. As a search strategy, information from articles/works sought in SCIELO, the Virtual
Health Library (BVS), Public Medline (PUBMED), and the Periódicos Capes platform is used
in the search, identifying original articles and review articles. bibliography between the years
2018 -2023, in order to collect studies related to the theme and the public in question. It is
concluded that the topic is highly relevant because it exposes questions about interactions
between meropenem and dobutamine, serving as literature to help health professionals, thus
avoiding possible errors and therapeutic failures. |
---|